Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Stockholders Equity Note [Abstract] |
|
| Summary of Stock Option Activity |
A summary of stock option activity under the Company’s current equity incentive plans during the six month period ended June 30, 2026, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options Outstanding |
|
|
|
Number of
Underlying Shares |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Life (in years) |
|
|
Aggregate
Intrinsic
Value |
|
Outstanding on January 1, 2026 |
|
|
621,539 |
|
|
$ |
2.81 |
|
|
|
5.37 |
|
|
$ |
9,705,525 |
|
Granted |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
|
- |
|
Forfeited / Canceled |
|
|
(9,315 |
) |
|
$ |
1.19 |
|
|
|
- |
|
|
|
(328,112 |
) |
Exercised |
|
|
(60,649 |
) |
|
$ |
3.13 |
|
|
|
- |
|
|
$ |
(912,698 |
) |
Outstanding on June 30, 2026 |
|
|
551,575 |
|
|
$ |
2.83 |
|
|
|
5.39 |
|
|
$ |
8,464,716 |
|
Exercisable as of June 30, 2026 |
|
|
451,575 |
|
|
$ |
2.81 |
|
|
|
5.05 |
|
|
$ |
6,941,716 |
|
|
| Schedule of Grant Date Fair Value of Options Vested and the Intrinsic Value of Options Exercised |
The following table presents the grant date fair value of options vested and the intrinsic value of options exercised:
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
Grant date fair value of options vested |
|
$ |
760,142 |
|
|
$ |
688,212 |
|
Intrinsic value of options exercised |
|
$ |
912,698 |
|
|
$ |
479,040 |
|
|
|
|
|
|
|
|
|
| Schedule of RSU Activity |
The Company’s RSU activity for the six months ended June 30, 2026, was as follows:
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units |
|
|
|
Number of
Underlying Shares |
|
|
Weighted
Average Grant
Date Fair Value |
|
Unvested on January 1, 2026 |
|
|
997,647 |
|
|
$ |
3.32 |
|
Granted |
|
|
484,743 |
|
|
$ |
10.34 |
|
Vested |
|
|
(410,070 |
) |
|
$ |
3.19 |
|
Canceled |
|
|
(26,136 |
) |
|
$ |
3.18 |
|
Unvested on June 30, 2026 |
|
|
1,046,184 |
|
|
$ |
6.62 |
|
|
| Summary of Stock-Based Compensation Expense Associated with Continuing Operations |
Stock-based compensation expense associated with continuing operations for the three and six month periods ended June 30, 2026 and 2025, was comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended June 30, |
|
|
For the Six Months Ended June 30, |
|
Stock-based compensation classified as: |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
General and administrative |
|
$ |
557,051 |
|
|
$ |
323,327 |
|
|
$ |
962,411 |
|
|
$ |
731,573 |
|
Production |
|
|
53,304 |
|
|
|
21,906 |
|
|
|
92,744 |
|
|
|
43,327 |
|
Marketing and selling |
|
|
179,704 |
|
|
|
89,312 |
|
|
|
325,141 |
|
|
|
181,082 |
|
Research and development |
|
|
71,154 |
|
|
|
48,805 |
|
|
|
136,045 |
|
|
|
105,773 |
|
|
|
$ |
861,213 |
|
|
$ |
483,350 |
|
|
$ |
1,516,341 |
|
|
$ |
1,061,755 |
|
|